Volumetric Arc Therapy
Showing 9976 - 10000 of >10,000
Anxiety Disorders and Symptoms, Depression, Anxiety, Generalized Anxiety Disorder Trial in New York (Emotion Regulation Therapy:
Completed
- Anxiety Disorders and Symptoms
- +3 more
- Emotion Regulation Therapy: 8-session version
- Emotion Regulation Therapy: 16-session version
-
New York, New YorkTeachers College, Columbia University
May 13, 2022
Dynamic Changes of Serum HBV RNA in Chronic Hepatitis B Patients
Not yet recruiting
- Chronic Hepatitis B Patients
-
Beijing, Beijing, ChinaBeijing Friendship Hospital, Capital Medical University
Aug 15, 2023
"Escape" Phenomenon of the Antihypertensive Therapy Efficacy
Active, not recruiting
- Arterial Hypertension
- Ambulatory blood pressure measurement device
- +3 more
-
Moscow, Russian FederationOksana Mikhailova
Jun 28, 2022
Continuum for Youth at HIV Risk, Acutely Infected and With
Active, not recruiting
- Human Immunodeficiency Virus
-
Los Angeles, California
- +2 more
Oct 24, 2022
Sexual Dysfunction, Sexual Arousal Disorder Trial in New Cairo (EROS device, Psychosexual support)
Recruiting
- Sexual Dysfunction
- Sexual Arousal Disorder
- EROS device
- Psychosexual support
-
New Cairo, Badr City, EgyptBadr University in Cairo
Jan 4, 2022
Increase Utilization of GDMT in Patients With HFrEF
Recruiting
- Heart Failure
- Using a clinical decision software to provide specific recommendation of a medication at a certain dosage
-
Los Angeles, CaliforniaCedars Sinai Medical Center
Apr 12, 2022
Melanoma, Atherosclerosis Trial in Clayton (Atorvastatin Calcium 40Mg Tab)
Not yet recruiting
- Melanoma
- Atherosclerosis
- Atorvastatin Calcium 40Mg Tab
-
Clayton, Victoria, AustraliaMonash Health
Apr 6, 2022
Acute Ischemic Stroke Trial in New Haven (NOVIS Transcarotid Neuroprotection System (NPS))
Recruiting
- Acute Ischemic Stroke
- NOVIS Transcarotid Neuroprotection System (NPS)
-
New Haven, ConnecticutYale University
Apr 26, 2022
Nivolumab Monotherapy or in Combination With Ipilimumab in
Active, not recruiting
- Melanoma
-
Essen, GermanyLocal Institution
Apr 25, 2022
Gastroesophageal Junction Adenocarcinoma Trial in Shijiazhuang (Oxaliplatin; Capecitabine, Oxaliplatin; Capecitabine; concurrent
Completed
- Gastroesophageal Junction Adenocarcinoma
- Oxaliplatin; Capecitabine
- Oxaliplatin; Capecitabine; concurrent radiotherapy
-
Shijiazhuang, Hebei, ChinaDepartment of General Surgery
Feb 4, 2022
Breast Tumors Trial in Granada (Cervical motor control)
Withdrawn
- Breast Neoplasms
- Cervical motor control
-
Granada, SpainUniversity of Granada
May 25, 2022
Heart Failure, Acute Decompensated Heart Failure Trial in Evanston (Impella BTR)
Recruiting
- Heart Failure
- Acute Decompensated Heart Failure
- Impella BTR
-
Evanston, IllinoisNorthwestern University
May 23, 2022
Hepatocellular Carcinoma, Hepatocellular Cancer, Hepatocellular Carcinoma Non-resectable Trial in Seoul (Atezolizumab plus
Recruiting
- Hepatocellular Carcinoma
- +4 more
- Atezolizumab plus bevacizumab, combined EBRT to vascular invasion
- Atezolizumab plus bevacizumab
-
Seoul, Korea, Republic ofAsan Medical Center
Aug 7, 2023
Covid-19, Pneumonia, Viral, Sars-CoV2 Trial in Sweden (Ciclesonide Inhalation Aerosol)
Active, not recruiting
- Covid-19
- +2 more
- Ciclesonide Inhalation Aerosol
-
Borås, Sweden
- +10 more
Jan 18, 2022
Colorectal Cancer Metastatic Trial in United States (durvalumab, Tremelimumab)
Completed
- Colorectal Cancer Metastatic
-
Duarte, California
- +17 more
Nov 8, 2022
Position in Spinal Stereotactic Body Radiation Therapy
Active, not recruiting
- Spinal Metastases
- mask for immobilization
- Elekta BodyFix
-
Houston, TexasMD Anderson Cancer Center
Feb 3, 2022
Prosthesis and Implants, Surgical Site Infection, Prosthetic Joint Infection Trial in Zurich (Photodynamic Therapy)
Not yet recruiting
- Prosthesis and Implants
- +3 more
- Photodynamic Therapy
-
Zurich, SwitzerlandUniversity Hospital of Zurich
Dec 22, 2022
Pulmonary Edema Cardiac Cause Trial (NPPV/HFNC, HFNC/NPPV)
Not yet recruiting
- Pulmonary Edema Cardiac Cause
- NPPV/HFNC
- HFNC/NPPV
- (no location specified)
Aug 2, 2023
Autism Spectrum Disorder, Neurodevelopmental Disorders, Cerebral Palsy Trial in Canada (ENGAGE approach (child-oriented
Recruiting
- Autism Spectrum Disorder
- +2 more
- ENGAGE approach (child-oriented goal-setting)
-
Calgary, Alberta, Canada
- +5 more
May 12, 2022
Acute Ischemic Stroke Trial in Los Angeles (Transcranial Direct Current Stimulation (tDCS))
Terminated
- Acute Ischemic Stroke
- Transcranial Direct Current Stimulation (tDCS)
-
Los Angeles, CaliforniaUniversity of California- Los Angeles (UCLA)
Apr 11, 2022
Advanced Renal Cell Carcinoma Trial in United States (CMN-001, Nivolumab+Ipilimumab, Lenvatinib+Everolimus)
Recruiting
- Advanced Renal Cell Carcinoma
- CMN-001
- +2 more
-
Tampa, Florida
- +6 more
Feb 10, 2022
Efficacy, Team, Adverse Reaction to Drug Trial in Chongqing (Sertraline)
Completed
- Efficacy, Team
- Adverse Reaction to Drug
-
Chongqing, Chongqing, ChinaThe First Affiliated Hospital of Chongqing Medical University
Nov 8, 2023
Quality of Life in Adult Chronic Lymphocytic Leukemia Receiving
Recruiting
- Chronic Lymphocytic Leukemia
-
Granada, Spain
- +4 more
Nov 8, 2023
Advanced Malignant Solid Tumor, RAS Mutation, Lung Cancer Trial in United States (RSC-1255 Dose Escalation, RSC-1255 Dose
Recruiting
- Advanced Malignant Solid Neoplasm
- +5 more
- RSC-1255 Dose Escalation
- RSC-1255 Dose Expansion
-
Los Angeles, California
- +5 more
Oct 24, 2022